- Home
- RRBI vs RGNX Comparison
RRBI vs RGNX Comparison
Compare RRBI & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRBI
- RGNX
- Stock Information
- Founded
- RRBI 1998
- RGNX 2008
- Country
- RRBI United States
- RGNX United States
- Employees
- RRBI N/A
- RGNX N/A
- Industry
- RRBI Hotels/Resorts
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RRBI Consumer Discretionary
- RGNX Health Care
- Exchange
- RRBI Nasdaq
- RGNX Nasdaq
- Market Cap
- RRBI 406.6M
- RGNX 445.5M
- IPO Year
- RRBI 2019
- RGNX 2015
- Fundamental
- Price
- RRBI $66.23
- RGNX $8.82
- Analyst Decision
- RRBI Buy
- RGNX Strong Buy
- Analyst Count
- RRBI 1
- RGNX 8
- Target Price
- RRBI $67.00
- RGNX $28.50
- AVG Volume (30 Days)
- RRBI 10.8K
- RGNX 687.5K
- Earning Date
- RRBI 07-30-2025
- RGNX 08-07-2025
- Dividend Yield
- RRBI 0.73%
- RGNX N/A
- EPS Growth
- RRBI 23.60
- RGNX N/A
- EPS
- RRBI 5.67
- RGNX N/A
- Revenue
- RRBI $115,623,000.00
- RGNX $155,782,000.00
- Revenue This Year
- RRBI $5.20
- RGNX $327.08
- Revenue Next Year
- RRBI $17.47
- RGNX N/A
- P/E Ratio
- RRBI $11.58
- RGNX N/A
- Revenue Growth
- RRBI 10.19
- RGNX 74.95
- 52 Week Low
- RRBI $46.33
- RGNX $5.04
- 52 Week High
- RRBI $66.40
- RGNX $13.48
- Technical
- Relative Strength Index (RSI)
- RRBI 65.37
- RGNX 53.29
- Support Level
- RRBI $61.25
- RGNX $7.83
- Resistance Level
- RRBI $66.40
- RGNX $9.24
- Average True Range (ATR)
- RRBI 1.47
- RGNX 0.51
- MACD
- RRBI 0.32
- RGNX 0.08
- Stochastic Oscillator
- RRBI 96.86
- RGNX 77.37
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.